Element Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Element Capital Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-19,260	Closed	-$509K	–	896
2019 Q1	$509K	Sell	19,260 -745	-4%	-$17.7K	0.02%	467
2018 Q4	$391K	Sell	20,005 -10,859	-35%	-$213K	0.01%	395
2018 Q3	$604K	Buy	30,864 +11,163	+57%	+$212K	0.01%	396
2018 Q2	$326K	Buy	19,701 +514	+3%	+$7.84K	0.01%	522
2018 Q1	$272K	Buy	+19,187	New	+$283K	0.01%	533

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Element Capital Management's HZNP Position: Q2 2019 in Review

Element Capital Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2019, closing a stake of 19,260 shares — an estimated $509K sold.

Element Capital Management first reported a position in HZNP in Q1 2018 and held it in 5 quarters. The position peaked at $604K in Q3 2018. 272 funds tracked by Wall St. Rank hold HZNP as of Q2 2019.

Element Capital Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2019 after selling out during the quarter.
Element Capital Management sold 19,260 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2019, an estimated $509K.
Element Capital Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2018 and held it in 5 quarters.
Element Capital Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $604K in Q3 2018.
272 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2019.

Based on Element Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.